![](/media/vdqhqzem/salmon.png)
Uppsala Reports editor
@UMCGlobalSafety
Communications / 24 February 2022
Photo: iStock
Informing patients and the public about risks is tricky. UMC's latest podcast digs into the evidence about what works best, and examines the proper role of health communicators.
People’s perception of risk can vary greatly from person to person, making it challenging for healthcare professionals to communicate benefits and harms of medicines in a balanced fashion.
Alexandra Freeman from the Winton Centre for Risk and Evidence Communication joins the Drug Safety Matters podcast to discuss how to give patients the information they need to decide what's best for them. This fascinating episode challenges assumptions about the role of the narratives in health communication and provides practical, evidence-backed guidance for conveying effective, ethical information about the potential harms and benefits of medicines and vaccines.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
The latest WHO PIDM film celebrates the long-standing collaboration between WHO and UMC to fulfil the mission of making medicines and vaccines safer for everyone.
Communications / 11 March 2024
With the misinformation pandemic still rife on the internet, finding websites with scientifically accurate vaccine information is quite the task. The VSN aims to change that.
Communications / 17 June 2024
Social media is prime real estate for healthcare communicators to connect with their audiences. But it is also constantly evolving. How can we navigate this dynamic online terrain?
Communications / 14 January 2025